A major discovery in cancer research is arising with the use of VHH fragments to reactivate dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in many types of cancer, leading https://bookmarksden.com/story22141936/mini-antibodies-restore-tumor-suppressor-p53-a-promising-hope-for-malignant-management